Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 6721

A sealed prediction that did not hold.

no effect in discovery (spearman rho +0.05, p 0.892). This receipt's hash covers every field on it, plus the hash of receipt 6720, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 6721
    22 Oct 2026, 19:01 UTC

    FOXP2

    microglia, braak

    predictionFOXP2 in microglia tracks Braak Lewy-body stage

    registered1e17ee56588b7bfc

    discovery+0.05 p=0.892 n=9

    replication-0.18 p=0.638 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho +0.05, p 0.892)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    882f80b418ccc7b8290715c0…
    follows 2bb1548056be…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 6721: FOXP2 in microglia, braak

power
full sample +0.01 (p 0.962, n 18), 95% CI -0.46 to +0.48. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: -0.00 (p 0.990, n 18). does not hold up.
composition
microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.02 (p 0.928, n 18). could be the mix.
skeptic
leave-one-out range -0.09 to +0.17, sign flips 7; without severely affected donors +0.01 (p 0.962, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for FOXP2 in microglia.

case closed: nothing better to follow up.